Intranasal Fentanyl for Breakthrough Pain Control

Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s7298
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Role of Intranasal Fentanyl in Breakthrough Pain Management in Cancer Patients

Cancer Management and Research
Oncology
2010English

Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

A New Fast-Acting Sublingual Fentanyl (Recivit®) for Treating Breakthrough Cancer Pain

European Oncology and Haematology
OncologyHematology
2014English

Budget Impact Analysis of the Fentanyl Buccal Tablet for Treatment of Breakthrough Cancer Pain

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2013English

Inhaled Methoxyflurane and Intranasal Fentanyl for Prehospital Management of Visceral Pain in an Australian Ambulance Service

Emergency Medicine Journal
MedicineCritical CareEmergency MedicineIntensive Care Medicine
2010English

Randomized Controlled Feasibility Trial of Intranasal Ketamine Compared to Intranasal Fentanyl for Analgesia in Children With Suspected Extremity Fractures

Academic Emergency Medicine
MedicineEmergency Medicine
2017English

Intrathecal Tramadol Versus Intrathecal Fentanyl for Visceral Pain Control During Bupivacaine Subarachnoid Block for Open Appendicectomy

Nigerian Journal of Clinical Practice
Medicine
2014English

Canadian Recommendations for the Management of Breakthrough Cancer Pain

Current Oncology
Oncology
2016English

Breakthrough Cancer Pain and Rational Drug Use

Supportive Care in Cancer
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy